We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Revolutionary Transistor Could Allow Wearable Devices to Measure Sodium and Potassium in Blood

By LabMedica International staff writers
Posted on 23 Jan 2023

Researchers have developed a revolutionary transistor that could be suitable for lightweight, flexible, high-performance bioelectronics. More...

The electrochemical transistor is compatible with blood and water and can amplify important signals, paving the way for its application in biomedical sensing. The transistor could allow for the use of wearable devices for onsite signal processing, right at the biology-device interface. Some of its likely applications could be for measuring heartbeat and the levels of sodium and potassium in blood, as well as eye motion in studies of sleep disorders.

The vertical electrochemical transistor developed by a transdisciplinary research team at Northwestern University (Evanston, IL, USA) is based on a new kind of electronic polymer and a vertical, instead of planar, architecture. The transistor conducts electricity as well as ions, and is stable in air. The design and synthesis of the new materials, and the fabrication and characterization of the transistor was made possible by the collaborative expertise of chemists, materials scientists and biomedical engineers in the research team.

In order to make electronic circuits more reliable and powerful, there is a need for two types of transistors: p-type transistors that carry positive charges and n-type transistors that carry negative charges. These types of circuits are called complementary circuits. In the past, researchers have faced a challenge in building n-type transistors which are also typically unstable. The work by the transdisciplinary research team is the first to demonstrate electrochemical transistors with similar and very high performance for both types (p+n) of electrochemical transistors. This helped the researchers fabricate highly efficient electrochemical complementary circuits.

“All modern electronics use transistors, which rapidly turn current on and off,” said Tobin J. Marks, a co-corresponding author of the study. “Here we use chemistry to enhance the switching. Our electrochemical transistor takes performance to a totally new level. You have all the properties of a conventional transistor but far higher transconductance (a measure of the amplification it can deliver), ultra-stable cycling of the switching properties, a small footprint that can enable high density integration, and easy, low-cost fabrication.”

“This exciting new type of transistor allows us to speak the language of both biological systems, which often communicate via ionic signaling, and electronic systems, which communicate with electrons,” said Jonathan Rivnay, professor of biomedical engineering at the McCormick School. “The ability of the transistors to work very efficiently as ‘mixed conductors’ makes them attractive for bioelectronic diagnostics and therapies.”

Related Links:
Northwestern University 


New
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Hematology Consumables
Bioblood Devices
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: The GenoPredict assay from Predicta Biosciences is available to Tempus Life Sciences partners to support exploratory research and clinical development programs (photo courtesy of Shutterstock)

Partnership Expands Ultrasensitive WGS Assay for for Hematologic Malignancies and MRD Monitoring

Tempus AI and Predicta Biosciences announced the commercial expansion of a co-branded whole‑genome sequencing assay GenoPredicta, which is intended for comprehensive genomic characterization of hematologic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.